Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of Adenovirus Vectors Expressing Epstein-Barr Virus (EBV) Immediate-Early Protein BZLF1 or BRLF1 To Treat EBV-Positive Tumors

4 Oct 2002

Abstract excerpt

The Epstein-Barr virus (EBV) genome is present in a variety of tumor types, including virtually all undifferentiated nasopharyngeal carcinomas (NPC) and a portion of gastric carcinomas. The uniform presence of the EBV genome in certain tumors (versus only a very small number of normal B cells) suggests that novel therapies which specifically target EBV-positive cells for destruction might be effective for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parvovirus B19 Infection Studies
Share to Viral-associated cancers and disorders
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12368338
DOI: 10.1128/jvi.76.21.10951-10959.2002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of Adenovirus Vectors Expressing Epstein-Barr Virus (EBV) Immediate-Early Protein BZLF1 or BRLF1 To Treat EBV-Positive TumorsPMID 12368338Read ↗

Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma CellsSemantic proximity Read ↗

Expression of the Epstein-Barr Virus Immediate Early Gene, BZLF1, in Nasopharyngeal Carcinoma Tumor CellsSemantic proximity Read ↗

The Therapeutic Potential of Targeting BARF1 in EBV-Associated MalignanciesSemantic proximity Read ↗

Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas.Semantic proximity Read ↗

Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in Northern China.Semantic proximity Read ↗

High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma.Semantic proximity Read ↗

Expression of the Epstein-Barr virus BHRF1 gene, a homologue of Bcl-2, in nasopharyngeal carcinoma tissue.Semantic proximity Read ↗

Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomasSemantic proximity Read ↗

EBV lytic infection enhances transformation of B‐lymphocytes infected with EBV in the presence of T‐lymphocytesSemantic proximity Read ↗

Lytic Viral Replication as a Contributor to theDetection of Epstein-Barr Virus in BreastCancerSemantic proximity Read ↗

An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.Semantic proximity Read ↗

Dominant‐negative derivative of EBNA1 represses EBNA1‐mediated transforming gene expression during the acute phase of Epstein–Barr virus infection independent of rapid loss of viral genomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.